Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone promote antiviral immune response by activating NF-ĸB

Nat Commun. 2025 Jan 8;16(1):496. doi: 10.1038/s41467-024-54882-y.

Abstract

Phenazine biosynthesis-like domain-containing protein (PBLD) and Cedrelone have been identified as tumor suppressors. However, their roles in virus infection remain unclear. Here, we demonstrate that PBLD upregulates the type I interferon (IFN-I) response through activating NF-kappaB (NF-κB) signaling pathway to resist viral infection in cells and mice. Mechanistically, PBLD activates NF-κB signaling pathway during viral infection via blocking tripartite motif containing 21 (TRIM21)-mediated phosphorylated inhibitory kappa B kinase beta (IKKβ) degradation. Furthermore, we show Cedrelone inhibits viral replication by increasing the PBLD protein expression and subsequently activating NF-κB-mediated IFN-I response. Furthermore, the therapeutic potential of Cedrelone lies in its ability to enhance antiviral immunity in primary macrophages and to promote survival and reduce lung tissue damage in HSV-1-infected mice in a PBLD-dependent manner. Consequently, our findings provide a potential combination model that targets PBLD for Cedrelone antiviral drug therapy, potentially paving the way for the development of broad-spectrum antiviral agents.

MeSH terms

  • Animals
  • Antiviral Agents* / pharmacology
  • Cyclohexanones / pharmacology
  • Female
  • HEK293 Cells
  • Herpes Simplex / drug therapy
  • Herpes Simplex / immunology
  • Herpes Simplex / virology
  • Herpesvirus 1, Human* / drug effects
  • Herpesvirus 1, Human* / immunology
  • Humans
  • I-kappa B Kinase / metabolism
  • Interferon Type I / immunology
  • Interferon Type I / metabolism
  • Intracellular Signaling Peptides and Proteins
  • Macrophages / drug effects
  • Macrophages / immunology
  • Macrophages / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • NF-kappa B* / metabolism
  • Phenazines / pharmacology
  • Signal Transduction* / drug effects
  • Virus Replication / drug effects

Substances

  • NF-kappa B
  • Antiviral Agents
  • I-kappa B Kinase
  • Interferon Type I
  • Cyclohexanones
  • Sipl1 protein, mouse
  • Phenazines
  • Intracellular Signaling Peptides and Proteins